PROS1 and allergic disease: Based on this strategy, and to avoid excess antigen load and allergic reactions in the host, this study aims to design an candidate vaccine against SADS-CoV S protein so that the constructed candidate vaccine can generate humoral and cell-mediated immunity, thereby achieving immune balance.